PGs and LTs have complementary effects on the pathogenesis of cancer and tumor progression, and thus dual COX-2/5-LO inhibition may represent a promising strategy to treat cancer and to prevent the pathogenesis of cancer [33,34,40]. Here, PTGS2 is linked to cancer.